Barclays PLC Increases Position in Core Laboratories Inc. (NYSE:CLB)

Barclays PLC grew its holdings in shares of Core Laboratories Inc. (NYSE:CLB) by 288.2% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 83,570 shares of the oil and gas company’s stock after purchasing an additional 62,042 shares during the period. Barclays PLC’s holdings in Core Laboratories were worth $1,549,000 as of its most recent SEC filing.

A number of other hedge funds have also recently made changes to their positions in CLB. Headlands Technologies LLC bought a new position in Core Laboratories in the 2nd quarter worth about $36,000. nVerses Capital LLC bought a new position in shares of Core Laboratories in the third quarter worth approximately $48,000. GAMMA Investing LLC lifted its stake in shares of Core Laboratories by 33.0% in the third quarter. GAMMA Investing LLC now owns 5,885 shares of the oil and gas company’s stock worth $109,000 after buying an additional 1,460 shares in the last quarter. Northwestern Mutual Wealth Management Co. grew its holdings in shares of Core Laboratories by 11.9% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 5,636 shares of the oil and gas company’s stock valued at $114,000 after buying an additional 600 shares during the last quarter. Finally, Signaturefd LLC increased its position in shares of Core Laboratories by 12.8% during the second quarter. Signaturefd LLC now owns 6,776 shares of the oil and gas company’s stock valued at $137,000 after acquiring an additional 767 shares in the last quarter. 97.81% of the stock is owned by institutional investors.

Core Laboratories Trading Down 1.9 %

Shares of CLB opened at $16.74 on Friday. The firm has a market cap of $785.94 million, a P/E ratio of 25.75, a price-to-earnings-growth ratio of 1.36 and a beta of 2.35. The company has a debt-to-equity ratio of 0.55, a current ratio of 2.48 and a quick ratio of 1.79. Core Laboratories Inc. has a 1 year low of $13.82 and a 1 year high of $25.13. The company has a 50 day simple moving average of $19.41 and a two-hundred day simple moving average of $19.63.

Core Laboratories (NYSE:CLB) last announced its quarterly earnings results on Wednesday, October 23rd. The oil and gas company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.04. The company had revenue of $134.40 million during the quarter, compared to analyst estimates of $134.16 million. Core Laboratories had a return on equity of 15.84% and a net margin of 5.83%. The firm’s revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.22 earnings per share. On average, equities analysts expect that Core Laboratories Inc. will post 0.8 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, November 25th. Shareholders of record on Monday, November 4th were paid a $0.01 dividend. The ex-dividend date was Monday, November 4th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.24%. Core Laboratories’s payout ratio is currently 6.15%.

Wall Street Analysts Forecast Growth

CLB has been the topic of a number of research analyst reports. StockNews.com raised Core Laboratories from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Citigroup lowered their target price on shares of Core Laboratories from $15.00 to $14.00 and set a “sell” rating on the stock in a research note on Thursday, October 31st. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $17.00.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.